
Natalie M. Moss
Examiner (ID: 15750, Phone: (571)270-7439 , Office: P/1653 )
| Most Active Art Unit | 1653 |
| Art Unit(s) | 1653 |
| Total Applications | 670 |
| Issued Applications | 186 |
| Pending Applications | 131 |
| Abandoned Applications | 392 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16778375
[patent_doc_number] => 20210115453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => TRANSPOSON SYSTEM AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/640807
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16640807
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/640807 | TRANSPOSON SYSTEM AND METHODS OF USE | Aug 30, 2018 | Abandoned |
Array
(
[id] => 16253850
[patent_doc_number] => 20200263224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => Methods for Antimicrobial Susceptibility Testing
[patent_app_type] => utility
[patent_app_number] => 16/639624
[patent_app_country] => US
[patent_app_date] => 2018-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16639624
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/639624 | Methods for Antimicrobial Susceptibility Testing | Aug 19, 2018 | Abandoned |
Array
(
[id] => 16718577
[patent_doc_number] => 20210085724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => CARDIOSPHERE-DERIVED CELLS AND THEIR EXTRACELLULAR VESICLES FOR TREATMENT AND PREVENTION OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/635142
[patent_app_country] => US
[patent_app_date] => 2018-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16635142
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/635142 | CARDIOSPHERE-DERIVED CELLS AND THEIR EXTRACELLULAR VESICLES FOR TREATMENT AND PREVENTION OF CANCER | Aug 1, 2018 | Abandoned |
Array
(
[id] => 15206519
[patent_doc_number] => 20190365946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => Compositions and Methods for Spine Fusion Procedures
[patent_app_type] => utility
[patent_app_number] => 15/973903
[patent_app_country] => US
[patent_app_date] => 2018-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15973903
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/973903 | Compositions and Methods for Spine Fusion Procedures | May 7, 2018 | Abandoned |
Array
(
[id] => 16484261
[patent_doc_number] => 20200377862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => METHOD FOR PREPARING CANCER STEMNESS CELL LINE THROUGH METABOLIC STRESS, AND CANCER CELL PREPARED THROUGH SAME
[patent_app_type] => utility
[patent_app_number] => 16/606795
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606795
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606795 | METHOD FOR PREPARING CANCER STEMNESS CELL LINE THROUGH METABOLIC STRESS, AND CANCER CELL PREPARED THROUGH SAME | Apr 19, 2018 | Abandoned |
Array
(
[id] => 16484261
[patent_doc_number] => 20200377862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => METHOD FOR PREPARING CANCER STEMNESS CELL LINE THROUGH METABOLIC STRESS, AND CANCER CELL PREPARED THROUGH SAME
[patent_app_type] => utility
[patent_app_number] => 16/606795
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606795
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606795 | METHOD FOR PREPARING CANCER STEMNESS CELL LINE THROUGH METABOLIC STRESS, AND CANCER CELL PREPARED THROUGH SAME | Apr 19, 2018 | Abandoned |
Array
(
[id] => 15797249
[patent_doc_number] => 20200121767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => METHODS FOR IDENTIFYING THE HEALTH STATE OF HYPOPHOSPHATASIA (HPP) PATIENTS
[patent_app_type] => utility
[patent_app_number] => 16/603927
[patent_app_country] => US
[patent_app_date] => 2018-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603927
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/603927 | METHODS FOR IDENTIFYING THE HEALTH STATE OF HYPOPHOSPHATASIA (HPP) PATIENTS | Apr 9, 2018 | Abandoned |
Array
(
[id] => 13551145
[patent_doc_number] => 20180327120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => New A-PRP Medical Device & Tissue Engineering Composition, Manufacturing Machines And Process
[patent_app_type] => utility
[patent_app_number] => 15/946524
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24904
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946524
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/946524 | New A-PRP Medical Device & Tissue Engineering Composition, Manufacturing Machines And Process | Apr 4, 2018 | Abandoned |
Array
(
[id] => 18436367
[patent_doc_number] => 20230183661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => BICOMPATIBLE PEPTIDEBIOCOMPATIBLE PEPTIDES FOR INHIBITION OF AGGREGATION OF B-AMYLOID PROTEIN
[patent_app_type] => utility
[patent_app_number] => 16/071340
[patent_app_country] => US
[patent_app_date] => 2018-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071340
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071340 | BICOMPATIBLE PEPTIDEBIOCOMPATIBLE PEPTIDES FOR INHIBITION OF AGGREGATION OF B-AMYLOID PROTEIN | Mar 28, 2018 | Abandoned |
Array
(
[id] => 13457539
[patent_doc_number] => 20180280312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => PACKAGED PROBIOTIC COMPOSITION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/933133
[patent_app_country] => US
[patent_app_date] => 2018-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13994
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15933133
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/933133 | PACKAGED PROBIOTIC COMPOSITION AND USES THEREOF | Mar 21, 2018 | Abandoned |
Array
(
[id] => 13311109
[patent_doc_number] => 20180207091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => Novel methods for delivering therapeutic agents to the eye via nasal passages
[patent_app_type] => utility
[patent_app_number] => 15/927327
[patent_app_country] => US
[patent_app_date] => 2018-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15927327
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/927327 | Novel methods for delivering therapeutic agents to the eye via nasal passages | Mar 20, 2018 | Abandoned |
Array
(
[id] => 13297749
[patent_doc_number] => 20180200411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => MATRIX CONSTRUCTION
[patent_app_type] => utility
[patent_app_number] => 15/907417
[patent_app_country] => US
[patent_app_date] => 2018-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5186
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15907417
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/907417 | MATRIX CONSTRUCTION | Feb 27, 2018 | Abandoned |
Array
(
[id] => 16963214
[patent_doc_number] => 20210214713
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2021-07-15
[patent_title] => METHODS FOR EXPERIMENTAL EVOLUTION OF NATURAL AND SYNTHETIC MICROBES
[patent_app_type] => utility
[patent_app_number] => 16/081975
[patent_app_country] => US
[patent_app_date] => 2018-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081975
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/081975 | METHODS FOR EXPERIMENTAL EVOLUTION OF NATURAL AND SYNTHETIC MICROBES | Feb 16, 2018 | Abandoned |
Array
(
[id] => 16963214
[patent_doc_number] => 20210214713
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2021-07-15
[patent_title] => METHODS FOR EXPERIMENTAL EVOLUTION OF NATURAL AND SYNTHETIC MICROBES
[patent_app_type] => utility
[patent_app_number] => 16/081975
[patent_app_country] => US
[patent_app_date] => 2018-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081975
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/081975 | METHODS FOR EXPERIMENTAL EVOLUTION OF NATURAL AND SYNTHETIC MICROBES | Feb 16, 2018 | Abandoned |
Array
(
[id] => 12746440
[patent_doc_number] => 20180140647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => Delivery System and Probiotic Composition for Animals and Plants
[patent_app_type] => utility
[patent_app_number] => 15/862201
[patent_app_country] => US
[patent_app_date] => 2018-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15862201
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/862201 | Delivery system and probiotic composition for animals and plants | Jan 3, 2018 | Issued |
Array
(
[id] => 15524709
[patent_doc_number] => 20200054660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => DNA METHYLATION PROFILING FOR T-CELL IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 16/467358
[patent_app_country] => US
[patent_app_date] => 2017-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19964
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467358
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/467358 | DNA METHYLATION PROFILING FOR T-CELL IMMUNOTHERAPY | Dec 6, 2017 | Pending |
Array
(
[id] => 15554371
[patent_doc_number] => 20200061597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => MAGNETICALLY IMMOBILIZED METABOLIC ENZYMES AND COFACTOR SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/465934
[patent_app_country] => US
[patent_app_date] => 2017-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16465934
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/465934 | MAGNETICALLY IMMOBILIZED METABOLIC ENZYMES AND COFACTOR SYSTEMS | Nov 27, 2017 | Pending |
Array
(
[id] => 12838345
[patent_doc_number] => 20180171288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => METHODS OF TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 15/819843
[patent_app_country] => US
[patent_app_date] => 2017-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26063
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15819843
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/819843 | METHODS OF TREATING CANCER | Nov 20, 2017 | Abandoned |
Array
(
[id] => 13490123
[patent_doc_number] => 20180296604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => METHOD FOR TREATMENT OF INFERTILITY, PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFERTILITY AND METHOD FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 15/819654
[patent_app_country] => US
[patent_app_date] => 2017-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15819654
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/819654 | METHOD FOR TREATMENT OF INFERTILITY, PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFERTILITY AND METHOD FOR PRODUCING THE SAME | Nov 20, 2017 | Abandoned |
Array
(
[id] => 16513207
[patent_doc_number] => 20200392465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => A PROCESS OF PREPARING BUCCAL EPITHELIAL CELL SUSPENSION AND ITS USE
[patent_app_type] => utility
[patent_app_number] => 15/761396
[patent_app_country] => US
[patent_app_date] => 2017-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15761396
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/761396 | A PROCESS OF PREPARING BUCCAL EPITHELIAL CELL SUSPENSION AND ITS USE | Nov 9, 2017 | Abandoned |